Back in 1965 when Girardi Keese first opened its doors, the issues were simple. Person A hurt Person B, but Person A did not mean to cause harm.
Over the years, however, we noticed a moral component entering into our legal work. Person A (often a big company, not a single person) made decisions knowing full well that Person B (plus lots of people like Person B) would be hurt. The big company, however, thought profits would far outweigh the risks. Person B became an unimportant casualty in the quest for quarterly income statements, stock options and dividends.
For the trial lawyers at Girardi
Keese, that is wrong. We have the resources and the passion to give a voice to people who have suffered personal injury and financial harm because of the often-deliberate actions of big companies — drug companies that sell drugs knowing they will do harm, car manufacturers that don't fix defects because it will cost a few dollars per car, big companies that knowingly allow discrimination and harassment of their employees, insurance companies that delay and deny rightful claims.
The list goes on — and Girardi
Keese keeps fighting back, providing a voice and a team of attorneys for people who have been injured. Other lawyers nationwide know that when they have tough cases that will take a lot of resources, they can count on us to ably and effectively represent their clients. And we make sure those lawyers are a part of our civil litigation team throughout the case.
You are welcome to review our practice areas and contact us. When our colleagues say, "It's a Girardi
Keese case," that means the case will get the resources it needs, that we will face the biggest companies in the world and that we will work for what is legally and morally right — fair compensation for every client. Our law firm represents clients in California and nationwide in cases involving personal injury, medical malpractice, product defects, employment law, aviation law and others.
Contact Girardi
Keese: 213-977-0211
http://www.girardikeese.com/
No comments:
Post a Comment